TrialSignal
Clinical trial intelligence report
The EUropean TRAnsplantation and INnovation Consortium for Risk Stratification in Kidney Transplant Patients
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT03652402-Jul 28, 2026
NCT ID
NCT03652402
Status
COMPLETED
Phase
registry-stage
Sponsor
Assistance Publique - Hôpitaux de Paris
Executive brief
Investment-Ready Snapshot
The EUropean TRAnsplantation and INnovation Consortium for Risk Stratification in Kidney Transplant Patients is a registry-stage clinical asset sponsored by Assistance Publique
Hôpitaux de Paris in Kidney Transplant Rejection, Kidney Transplantation, Risk Stratification, Prognosis. SEO and diligence focus: kidney transplantation, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT03652402
Indication
Kidney Transplant Rejection
Modality
RNA therapy
Target
kidney transplantation
Intervention
kidney transplantation
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.